TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

GlaxoSmithKline discloses bribery inquiries

By The Associated Press
Thursday, April 17, 2014, 12:01 a.m.
 

British drugmaker GlaxoSmithKline is looking into allegations of bribery within its operations in Jordan and Lebanon.

On Monday, the BBC reported that GlaxoSmithKline PLC is involved in a bribery investigation in Poland, where a sales representative allegedly paid doctors to prescribe the company's asthma drug Seretide. The company said it learned of the allegations in 2011 and found evidence of inappropriate communications by an employee. It says that employee was disciplined.

The company is dealing with a corruption investigation in China and is looking into alleged bribery in Iraq.

 

 
 


Show commenting policy

Most-Read Business Headlines

  1. Few homeowners expected to benefit from Bank of America’s $16.65B settlement
  2. Thousands of American steel jobs believed lost to import surge
  3. Utility regulator seeks $639,000 in penalties from electric supplier
  4. Dynegy to spend $6.25B on power plant acquisitions
  5. Advocacy group requests investigation of Chrysler power system failures
  6. Microsoft keeping $93B offshore, off U.S. tax rolls
  7. GM’s legal team targeted in federal investigation
  8. Central banks around globe moving in different directions
  9. Beware mergers’ bad spawn
  10. Instead of clarity, Federal Reserve Chair Yellen offers more uncertainty on interest rate hikes
  11. Google Maps opens business doors to online views for shoppers
Subscribe today! Click here for our subscription offers.